ArticleTherapeutic advances in neurological disorders2021

Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study.

Jeremias Motte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.